Citation Impact
Citing Papers
Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro
2006 StandoutNobel
Superinfection Exclusion in Cells Infected with Hepatitis C Virus
2007 StandoutNobel
Mouse models of acute and chronic hepacivirus infection
2017 StandoutScienceNobel
Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1)
2013 StandoutNobel
Persistent Hepatitis C Virus Infection In Vitro: Coevolution of Virus andHost
2006
Hepatitis C virus infection acquired in childhood
2007
The natural course of HCV infection and the need for treatment
2008
The Spring α-Helix Coordinates Multiple Modes of HCV (Hepatitis C Virus) NS3 Helicase Action
2016 StandoutNobel
Global epidemiology and genotype distribution of the hepatitis C virus infection
2014
Should hepatitis B vaccination be introduced into childhood immunisation programmes in northern Europe?
2007
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
2009 StandoutNature
Hepatitis C Virus Infection
2001 Standout
Spontaneous clearance of childhood hepatitis C virus infection
2007
Recombinant alfa-interferon plus ribavirin therapy in children and adolescents with chronic hepatitis C
2002
Unravelling hepatitis C virus replication from genome to function
2005 StandoutNatureNobel
Architects of assembly: roles of Flaviviridae non-structural proteins in virion morphogenesis
2008 StandoutNobel
Expression of paramyxovirus V proteins promotes replication and spread of hepatitis C virus in cultures of primary human fetal liver cells
2010 StandoutNobel
Treatment of Acute Hepatitis C with Interferon Alfa-2b
2001
Course and outcome of hepatitis C
2002
Prevalence of hepatitis C virus infection in urban children
2003
Natural history of chronic hepatitis C
2002
A Humanized Mouse Model to Study Hepatitis C Virus Infection, Immune Response, and Liver Disease
2011 StandoutNobel
Hepatitis B virus infection
2009 Standout
Hepatitis C Virus Continuously Escapes From Neutralizing Antibody and T-Cell Responses During Chronic Infection In Vivo
2006 StandoutNobel
Cell entry of hepatitis C virus
2006
Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection
2006 StandoutNobel
Long-Term Course of Chronic Hepatitis C in Children: From Viral Clearance to End-Stage Liver Disease
2008
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Prospects for a vaccine against the hepatitis C virus
2005 StandoutNatureNobel
Clinical Spectrum and Histopathologic Features of Chronic Hepatitis C Infection in Children
2007
Cell culture–produced hepatitis C virus does not infect peripheral blood mononuclear cells
2008 StandoutNobel
Natural history of hepatitis C: Its impact on clinical management
2000
Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in germany: A 20-year multicenter study
2000
The Humoral Immune Response to HCV: Understanding is Key to Vaccine Development
2014
The ins and outs of hepatitis C virus entry and assembly
2013 StandoutNobel
The Natural History of Hepatitis C Virus Infection
2000
American Gastroenterological Association Technical Review on the Management of Hepatitis C
2006
Oxidized low-density lipoprotein inhibits hepatitis C virus cell entry in human hepatoma cells
2006 StandoutNobel
Hepatitis C and renal disease: an update
2003
Advances in Model Systems for Hepatitis C Virus Research
2002
Enhanced Activation of Memory, but Not Naïve, B Cells in Chronic Hepatitis C Virus-Infected Patients with Cryoglobulinemia and Advanced Liver Fibrosis
2013 StandoutNobel
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
2009 StandoutNature
Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry
2007 StandoutNatureNobel
Hepatitis C Virus Entry
2007 StandoutNobel
Prevalence of Hepatitis C Infection in Adult Patients Who Underwent Congenital Heart Surgery Prior to Screening in 1992
2007
The management of HCV infected pregnant women and their children European paediatric HCV network
2005
Recovery, Persistence, and Sequelae in Hepatitis C Virus Infection: A Perspective on Long-Term Outcome
2000
The Natural History of Hepatitis C Virus (HCV) Infection
2006
Clearance of hepatitis C virus RNA from the peripheral blood mononuclear cells of blood donors who spontaneously or therapeutically control their plasma viremia
2008
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
Assessment of Fibrosis Progression in Untreated Irish Women With Chronic Hepatitis C Contracted From Immunoglobulin Anti-D
2006
A Hepatitis C Virus (HCV) Vaccine Comprising Envelope Glycoproteins gpE1/gpE2 Derived from a Single Isolate Elicits Broad Cross-Genotype Neutralizing Antibodies in Humans
2013 StandoutNobel
Children with hepatitis C
2002
Chronic hepatitis C with normal aminotransferase levels
2004
Secretion of Hepatitis C Virus Envelope Glycoproteins Depends on Assembly of Apolipoprotein B Positive Lipoproteins
2009
Peginterferon alfa‐2b plus ribavirin treatment in children and adolescents with chronic hepatitis C†
2005
The way forward in HCV treatment — finding the right path
2007 StandoutNobel
New therapeutic strategies for hepatitis C
2002 StandoutNobel
The burden of hepatitis C virus infection in children: Estimated direct medical costs over a 10-year period
2006
Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons
2017 StandoutNobel
Mathematical modeling of primary hepatitis C infection: Noncytolytic clearance and early blockage of virion production
2005 StandoutNobel
Estimating progression to cirrhosis in chronic hepatitis C virus infection
2001
Replication of hepatitis C virus
2007 StandoutNobel
Children with hepatitis C
2002
Cellular Determinants of Hepatitis C Virus Assembly, Maturation, Degradation, and Secretion
2007
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
Amphipathic Helix-Dependent Localization of NS5A Mediates Hepatitis C Virus RNA Replication
2003 StandoutNobel
Ultrastructural analysis of hepatitis C virus particles
2013 StandoutNobel
Natural History of Hepatitis C
2005
An Interplay between Hypervariable Region 1 of the Hepatitis C Virus E2 Glycoprotein, the Scavenger Receptor BI, and High-Density Lipoprotein Promotes both Enhancement of Infection and Protection against Neutralizing Antibodies
2005
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
High-Avidity Monoclonal Antibodies against the Human Scavenger Class B Type I Receptor Efficiently Block Hepatitis C Virus Infection in the Presence of High-Density Lipoprotein
2007 StandoutNobel
An N-Terminal Amphipathic Helix in Hepatitis C Virus (HCV) NS4B Mediates Membrane Association, Correct Localization of Replication Complex Proteins, and HCV RNA Replication
2004 StandoutNobel
Divergent and convergent evolution after a common-source outbreak of hepatitis C virus
2005
Course and outcome of hepatitis C
2002
Studying Hepatitis C Virus: Making the Best of a Bad Virus
2007 StandoutNobel
Highly Permissive Cell Lines for Subgenomic and Genomic Hepatitis C Virus RNA Replication
2002 StandoutNobel
Hepatitis C Virus p7 and NS2 Proteins Are Essential for Production of Infectious Virus
2007 StandoutNobel
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
2007 Standout
Efficient Replication of Hepatitis C Virus Genotype 1a RNAs in Cell Culture
2003 StandoutNobel
Kinetics of CD4+and CD8+Memory T-Cell Responses during Hepatitis C Virus Rechallenge of Previously Recovered Chimpanzees
2003 StandoutNobel
Modulation of Hepatitis C Virus RNA Abundance by a Liver-Specific MicroRNA
2005 StandoutScience
Viral persistence, liver disease, and host response in a hepatitis C–like virus rat model
2017 StandoutNobel
Human Serum Facilitates Hepatitis C Virus Infection, and Neutralizing Responses Inversely Correlate with Viral Replication Kinetics at the Acute Phase of Hepatitis C Virus Infection
2005
Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agents
2014 StandoutNobel
Mutations in Hepatitis C Virus E2 Located outside the CD81 Binding Sites Lead to Escape from Broadly Neutralizing Antibodies but Compromise Virus Infectivity
2009 StandoutNobel
Immune control and failure in HCV infection—tipping the balance
2014
Ultrastructural and Biophysical Characterization of Hepatitis C Virus Particles Produced in Cell Culture
2010
Chronic Hepatitis C Virus Infection in Childhood: Clinical Patterns and Evolution in 224 White Children
2003
De novo infection and propagation of wild-type Hepatitis C virus in human T lymphocytes in vitro
2006
Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance1 1The Bundesministerium für Bildung und Forschung and the European Union, as sponsors of the study, had no role in study design, data collection, analysis, or interpretation or in the writing and the decision to submit the report for publication.
2003
Differential Biophysical Properties of Infectious Intracellular and Secreted Hepatitis C Virus Particles
2006
Hepatitis C in Children
2006
Natural history of chronic hepatitis C
2002
Intrahepatic Genetic Inoculation of Hepatitis C Virus RNA Confers Cross-Protective Immunity
2001 StandoutNobel
Role of Scavenger Receptor Class B Type I in Hepatitis C Virus Entry: Kinetics and Molecular Determinants
2009 StandoutNobel
Structure of the catalytic domain of the hepatitis C virus NS2-3 protease
2006 StandoutNatureNobel
Works of Barbara Langer being referenced
Prevalence and Clinical Outcome of Hepatitis C Infection in Children Who Underwent Cardiac Surgery before the Implementation of Blood-Donor Screening
1999
Hepatitis C virus particles of different density in the blood of chronically infected immunocompetent and immunodeficient patients: Implications for virus clearance by antibody
2002
Hepatitis B vaccination in a school age population: a feasibility study
2005
Changes in hypervariable region 1 of the envelope 2 glycoprotein of hepatitis C virus in children and adults with humoral immune defects
2003
Prevalence and Clinical Outcome of Hepatitis C Infection in Children Who Underwent Cardiac Surgery Before the Implementation of Blood-Donor Screening
2000